Nascent Biotech & Manhattan Bio: Pritumumab ADC Collaboration

Nascent Biotech, Inc., a clinical biotechnology company, announced that it has entered into a research collaboration agreement for antibody-drug conjugate (ADC) research with Manhattan BioSolutions, Inc.

Piramal Pharma's US Facility Receives 3 FDA Observations

Piramal Pharma said the US Food and Drug Administration (USFDA) have conducted the pre-approval test (PAI) at its Riverview facility in the US.

Jazz Pharma Acquires Global Rights to Redx's KRAS Inhibitor

Jazz Pharmaceuticals plc, a global biopharmaceutical company, and Redx Pharma plc, a clinical-stage biotechnology company, announced that the companies had signed a definitive agreement under which Jazz will acquire

Parse Biosciences and Integra Ink Pact For Automated Single Cell Workflows

Parse Biosciences, a main supplier of open and versatile single cell sequencing arrangements, reported it has gone into a concurrence with Integra Biosciences to coordinate the Help In addition to with worked in Parse Evercode single cell...

Award for Glocal Hospital in Begusarai under Ayushman Bharat

The Begusarai district administration awarded Glocal Hospital Begusarai for its outstanding performance under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana. The award was presented to hospital director

HCG Cancer Centre's World Cancer Day 2024 Awareness Center in Bengaluru

HCG Cancer Center, Bangalore has launched several initiatives through the 'Power of Good Wishes' campaign, inspired by the heart-warming faith 'Jo dawa nahi kar paati, wo dua kar paati hai' (What can't medicine do) on Cancer Day.

ACS and Pfizer's $15M Cancer Care Disparity Initiative

The American Cancer Society (ACS) and Pfizer Inc. announced the launch of "Changing the Odds: A Partnership to Improve Cancer Outcomes," a three-year plan to address gaps in cancer care.

JB Pharma Q3 FY24 Net Profit Soars 26% to Rs. 134 Crore

JB Chemicals and Pharmaceuticals Ltd (JB Pharma), one of India's fastest-growing pharmaceutical companies, announced its financial results for the quarter that ended December 31, 2023.

Molbio Diagnostics Launches 'EDGE' Healthcare Innovation Program

Molvio Diagnostics, a leader in in-house diagnostic diagnostics, has launched 'EDGE,' a state-of-the-art collaborative program dedicated to accelerating gaming therapy technologies

Lupin Secures Nod From US FDA for Bromfenac Ophthalmic Solution

Lupine Limited (hereafter Lupin), an international pharmaceutical company, has received approval from the US Food and Drug Administration (FDA) to submit a New Drug Application for Bromfenac 0.075% Ophthalmic Solution to be marketed as a vaccine

© 2024 India Pharma Outlook. All Rights Reserved.